A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
NCT07712939
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
105
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Participants Study
Rheumatoid Arthritis
Sjogren's Syndrome
Interventions
BIOLOGICAL:
CND319
Sponsor
Candid Therapeutics